Zynerba Pharmaceuticals, Inc.
Treatment of autism with cannabidiol

Last updated:

Abstract:

The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.

Status:
Grant
Type:

Utility

Filling date:

14 May 2019

Issue date:

25 Feb 2020